Recap: IN8bio Q2 Earnings
IN8bio (NASDAQ:INAB) reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
IN8bio, Inc. – Common Stock Q2 EPS $(0.38) Up From $(1.00) YoY
IN8bio, Inc. - Common Stock (NASDAQ:INAB) reported quarterly losses of $(0.38) per share. This is a 62 percent increase over losses of $(1.00) per share from the same period last year.
IN8bio Priced Thursday ~5.39M Share Public Offering of Common Stock @$1.90/Share
N8bio, Inc. (Nasdaq: INAB) announced the pricing of an underwritten public offering of 5,394,737 shares of its common stock at a public offering price of $1.90 per share.
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
Recap of Wednesday’s Biotech Catalysts – End of The Day Summary
IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate…
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
IN8Bio Announces Positive Glioblastoma Multiforme (Gbm) Clinical Updates From The INB-200 Phase 1 Trial Presented At ASCO 2022
100% of dosed patients have exceeded both median and expected progression free survival (PFS). Two patients, to date, having exceeded their expected overall survival (OS).
An unmethylated GBM
110 Biggest Movers From Friday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
